Phillip Frost Reports 571,429 Pre-Funded Warrants and 571,429 Warrants in FLNT
Rhea-AI Filing Summary
Phillip Frost, M.D., and Frost Gamma Investments Trust reported acquisitions in Fluent, Inc. (FLNT) on 08/19/2025. The filing shows the purchase of 571,429 pre-funded warrants (priced at $0.0005 each and immediately exercisable for one share) and 571,429 warrants with an exercise price of $2.21. Each class corresponds to 571,429 underlying common shares and is held indirectly by Frost Gamma Investments Trust. The report lists total beneficial ownership following the transactions as 571,429 shares for each instrument.
The filing includes an ownership chain explanation identifying Dr. Frost as trustee of Frost Gamma Investments Trust and outlining related entities; the reporting persons disclaim beneficial ownership except to the extent of any pecuniary interest.
Positive
- Clear disclosure of acquisitions: The Form 4 reports acquisition of 571,429 pre-funded warrants and 571,429 warrants on 08/19/2025.
- Immediate exercisability disclosed: The pre-funded warrants are stated as immediately exercisable for one share each.
- Transparent ownership chain: The filing explains the indirect ownership structure through Frost Gamma entities and identifies Dr. Phillip Frost as trustee.
Negative
- None.
Insights
TL;DR: Insider entity acquired 571,429 pre-funded warrants and 571,429 warrants on 08/19/2025; holdings are held indirectly.
The Form 4 discloses two contemporaneous acquisitions: pre-funded warrants immediately exercisable for common shares and standard warrants exercisable at $2.21. Both were acquired on 08/19/2025 and are held indirectly by Frost Gamma Investments Trust. The filing is a routine Section 16 disclosure detailing issuance and ownership structure, including a clear chain of control identifying Dr. Phillip Frost as trustee. No exercise or disposition was reported within this form.
TL;DR: Transaction is a standard insider disclosure with an ownership explanation; it clarifies indirect ownership through affiliated entities.
The document provides the statutory explanation of indirect ownership through Frost Gamma entities and includes signed attestations by Dr. Frost as trustee and individually. The explanation follows common practice for affiliated-entity holdings and contains no statements of amendment or correction. This is a compliance-focused filing rather than a corporate governance change or leadership shift.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Pre-Funded Warrants | 571,429 | $1.75 | $1.00M |
| Grant/Award | Warrants | 571,429 | $0.00 | -- |
Footnotes (1)
- These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Each Pre-Funded Warrant is immediately exercisable for one share of the issuer's common stock, $0.0005 par value per share (the "Common Stock"), and will expire when exercised in full. Each Warrant will be exercisable for one share of Common Stock at any time on or after the date that is six months and one day following the date of issuance for a period of five and one-half years from the date of issuance. Notwithstanding the foregoing, the Warrants shall be exercisable at any time on or after the date that applicable stockholder approval is obtained and deemed effective and such Warrants shall be exercisable until the expiration date.
